Home
>
National Drug Code (NDC)
>
Myrbetriq
Myrbetriq - 0469-2602-30 - (mirabegron)
Drug Information of Myrbetriq
| Product NDC: | 0469-2602 |
| Proprietary Name: | Myrbetriq |
| Non Proprietary Name: | mirabegron |
| Active Ingredient(s): | 50 mg/1 & nbsp; mirabegron |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Myrbetriq
| Product NDC: | 0469-2602 |
| Labeler Name: | Astellas Pharma US, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202611 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120628 |
Package Information of Myrbetriq
| Package NDC: | 0469-2602-30 |
| Package Description: | 1 BOTTLE in 1 CARTON (0469-2602-30) > 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE |
NDC Information of Myrbetriq
| NDC Code | 0469-2602-30 |
| Proprietary Name | Myrbetriq |
| Package Description | 1 BOTTLE in 1 CARTON (0469-2602-30) > 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE |
| Product NDC | 0469-2602 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mirabegron |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120628 |
| Marketing Category Name | NDA |
| Labeler Name | Astellas Pharma US, Inc. |
| Substance Name | MIRABEGRON |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | beta3-Adrenergic Agonist [EPC],Adrenergic beta3-Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
